About
Community Oncology Partners is an owner-operator of medical oncology practices that designs, develops, and invests in our sites of care within the communities we serve. Our growth platform model was built around giving our providers long-term financial incentives to provide best-in-class care to our most vulnerable communities.
Our Mission
Our Vision
Our vision is to provide excellent, evidence-based care for each patient we serve while continuously advancing cancer care. We strive to be at the forefront of innovation, research, and compassionate treatment, ensuring that our community members receive the highest quality of care in their fight against cancer.
Develop, own, and operate 300+ de novo (new build, new operation) medical oncology and specialty infusion clinics
Provide expanded care in underserved and rural markets
Provide vulnerable communities with cancer treatment
Form cohesive and durable treatment teams for long-term community benefit
Why COP?
Our Team
Community Oncology Partners Management Team
Shaman Bakshi
CEO
David Weissberg
President
Brian Willis
Chief Clinical Officer
Anthony Mikelonis
CFO
Advisory Board
James Hamrick, MD, MPH
Board-Certified Medical Oncologist, Hematologist, and Internist
Denise Brown, MD
Healthcare Management Executive and Board Director
Leland Green, MD
Board-Certified Medical Oncologist, Hematologist, and Internist
Tesh Khullar
Cofounder and President, House RX
Douglas Anning
Sara J. Finley
Former Senior Vice President and General Counsel, CVS Caremark Corporation
How We Support
Patients, Providers, and Staff
We provide state-of-the-art care centers that are designed and constructed to support patient outcomes and experience, improve physician recruitment and retention, improve staff retention, and ensure that our sites are a fixture of our communities.
Leadership
Enterprise management
Compliance
Quality and safety
Practice management
Financial
Administrative
Business services
COP is your operational AND development partner.
We partner in securing land, permitting and construction, USP 800 compliance, and recruiting and training to develop and operate multiple de novo sites to meet the oncology demand in the locations we serve.
Ready to learn more?
Start a conversation with us!